COVID-19-associated brief psychotic disorder.
Level 4 - case-series / case-control
Individual case report
PubMed 32784244 · doi:10.1136/bcr-2020-236940
What was done
Clinical case report of a previously healthy 36-year-old woman with no personal or family history of mental illness who developed new-onset psychosis following a diagnosis of symptomatic COVID-19.
What was found
No quantitative data were reported in the abstract. The patient presented with acute psychosis after symptomatic COVID-19. Her psychiatric symptoms improved initially with antipsychotics and benzodiazepines and showed further improvement following the resolution of her COVID-19 symptoms.
Why it matters
This report describes acute psychosis emerging in the context of symptomatic COVID-19 in an individual without prior psychiatric history, underscoring the need for clinical vigilance for acute neuropsychiatric presentations during infection.
Limits
This is an uncontrolled single-patient case report (n = 1), which cannot establish causality, incidence, or generalizability. The abstract does not report specific laboratory or neuroimaging findings, medication dosing, or duration of follow-up.
Cited by
- supports Published studies have documented new-onset psychosis as a rare post-infection complication in previously healthy individuals who contracted COVID-19.